Can APOE and MTHFR polymorphisms have an influence on the severity of cardiovascular manifestations in Italian Pseudoxanthoma elasticum affected patients?

Background: The clinical phenotype of Pseudoxanthoma elasticum (PXE) affected patients, although progressive with age, is very heterogeneous, even in the presence of identical ABCC6 mutations, thus suggesting the occurrence of modifier genes. Beside typical skin manifestations, the cardiovascular (C...

Full description

Bibliographic Details
Main Authors: Federica Boraldi, Sonia Costa, Claudio Rabacchi, Miriam Ciani, Olivier Vanakker, Daniela Quaglino
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Molecular Genetics and Metabolism Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221442691400072X
_version_ 1828377093614862336
author Federica Boraldi
Sonia Costa
Claudio Rabacchi
Miriam Ciani
Olivier Vanakker
Daniela Quaglino
author_facet Federica Boraldi
Sonia Costa
Claudio Rabacchi
Miriam Ciani
Olivier Vanakker
Daniela Quaglino
author_sort Federica Boraldi
collection DOAJ
description Background: The clinical phenotype of Pseudoxanthoma elasticum (PXE) affected patients, although progressive with age, is very heterogeneous, even in the presence of identical ABCC6 mutations, thus suggesting the occurrence of modifier genes. Beside typical skin manifestations, the cardiovascular (CV) system, and especially the peripheral vasculature, is frequently and prematurely compromised. Methods and results: A cohort of 119 Italian PXE patients has been characterized for apolipoprotein E (APOE) and methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms by PCR. The severity of the clinical phenotype has been quantified according to the Phenodex PXE International score system. Statistical analysis (chi2 test, odd ratio, regression analysis, analysis of variance) were done by GraphPad. Data demonstrate that the frequency of APOE alleles is similar in PXE patients and in healthy subjects and that the allelic variant E2 confers a protection against the age-related increase of CV manifestations. By contrast, PXE patients are characterized by high frequency of the MTHFR-T677T polymorphism. With age, CV manifestations in T677T, but also in C677T, patients are more severe than those associated with the C677C genotype. Interestingly, compound heterozygosity for C677T and A1298C polymorphisms is present in 70% of PXE patients. Conclusions: PXE patients may be screened for these polymorphisms in order to support clinicians for a better management of disease-associated CV complications.
first_indexed 2024-04-14T08:09:08Z
format Article
id doaj.art-94995bb75f8c4db6a8e9e4e9f8313dbd
institution Directory Open Access Journal
issn 2214-4269
language English
last_indexed 2024-04-14T08:09:08Z
publishDate 2014-01-01
publisher Elsevier
record_format Article
series Molecular Genetics and Metabolism Reports
spelling doaj.art-94995bb75f8c4db6a8e9e4e9f8313dbd2022-12-22T02:04:38ZengElsevierMolecular Genetics and Metabolism Reports2214-42692014-01-011C47748210.1016/j.ymgmr.2014.11.002Can APOE and MTHFR polymorphisms have an influence on the severity of cardiovascular manifestations in Italian Pseudoxanthoma elasticum affected patients?Federica Boraldi0Sonia Costa1Claudio Rabacchi2Miriam Ciani3Olivier Vanakker4Daniela Quaglino5Department of Life Sciences, University of Modena and Reggio Emilia, Modena, ItalyDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, ItalyDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, ItalyDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, ItalyCenter for Medical Genetics, Ghent University Hospital, Ghent, BelgiumDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, ItalyBackground: The clinical phenotype of Pseudoxanthoma elasticum (PXE) affected patients, although progressive with age, is very heterogeneous, even in the presence of identical ABCC6 mutations, thus suggesting the occurrence of modifier genes. Beside typical skin manifestations, the cardiovascular (CV) system, and especially the peripheral vasculature, is frequently and prematurely compromised. Methods and results: A cohort of 119 Italian PXE patients has been characterized for apolipoprotein E (APOE) and methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms by PCR. The severity of the clinical phenotype has been quantified according to the Phenodex PXE International score system. Statistical analysis (chi2 test, odd ratio, regression analysis, analysis of variance) were done by GraphPad. Data demonstrate that the frequency of APOE alleles is similar in PXE patients and in healthy subjects and that the allelic variant E2 confers a protection against the age-related increase of CV manifestations. By contrast, PXE patients are characterized by high frequency of the MTHFR-T677T polymorphism. With age, CV manifestations in T677T, but also in C677T, patients are more severe than those associated with the C677C genotype. Interestingly, compound heterozygosity for C677T and A1298C polymorphisms is present in 70% of PXE patients. Conclusions: PXE patients may be screened for these polymorphisms in order to support clinicians for a better management of disease-associated CV complications.http://www.sciencedirect.com/science/article/pii/S221442691400072XPseudoxanthoma elasticumSkin-diseaseApolipoprotein EMethylenetetrahydrofolate reductaseCardiovascular
spellingShingle Federica Boraldi
Sonia Costa
Claudio Rabacchi
Miriam Ciani
Olivier Vanakker
Daniela Quaglino
Can APOE and MTHFR polymorphisms have an influence on the severity of cardiovascular manifestations in Italian Pseudoxanthoma elasticum affected patients?
Molecular Genetics and Metabolism Reports
Pseudoxanthoma elasticum
Skin-disease
Apolipoprotein E
Methylenetetrahydrofolate reductase
Cardiovascular
title Can APOE and MTHFR polymorphisms have an influence on the severity of cardiovascular manifestations in Italian Pseudoxanthoma elasticum affected patients?
title_full Can APOE and MTHFR polymorphisms have an influence on the severity of cardiovascular manifestations in Italian Pseudoxanthoma elasticum affected patients?
title_fullStr Can APOE and MTHFR polymorphisms have an influence on the severity of cardiovascular manifestations in Italian Pseudoxanthoma elasticum affected patients?
title_full_unstemmed Can APOE and MTHFR polymorphisms have an influence on the severity of cardiovascular manifestations in Italian Pseudoxanthoma elasticum affected patients?
title_short Can APOE and MTHFR polymorphisms have an influence on the severity of cardiovascular manifestations in Italian Pseudoxanthoma elasticum affected patients?
title_sort can apoe and mthfr polymorphisms have an influence on the severity of cardiovascular manifestations in italian pseudoxanthoma elasticum affected patients
topic Pseudoxanthoma elasticum
Skin-disease
Apolipoprotein E
Methylenetetrahydrofolate reductase
Cardiovascular
url http://www.sciencedirect.com/science/article/pii/S221442691400072X
work_keys_str_mv AT federicaboraldi canapoeandmthfrpolymorphismshaveaninfluenceontheseverityofcardiovascularmanifestationsinitalianpseudoxanthomaelasticumaffectedpatients
AT soniacosta canapoeandmthfrpolymorphismshaveaninfluenceontheseverityofcardiovascularmanifestationsinitalianpseudoxanthomaelasticumaffectedpatients
AT claudiorabacchi canapoeandmthfrpolymorphismshaveaninfluenceontheseverityofcardiovascularmanifestationsinitalianpseudoxanthomaelasticumaffectedpatients
AT miriamciani canapoeandmthfrpolymorphismshaveaninfluenceontheseverityofcardiovascularmanifestationsinitalianpseudoxanthomaelasticumaffectedpatients
AT oliviervanakker canapoeandmthfrpolymorphismshaveaninfluenceontheseverityofcardiovascularmanifestationsinitalianpseudoxanthomaelasticumaffectedpatients
AT danielaquaglino canapoeandmthfrpolymorphismshaveaninfluenceontheseverityofcardiovascularmanifestationsinitalianpseudoxanthomaelasticumaffectedpatients